Abayomi Sijuade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abayomi Sijuade has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Christian Tientcha Happi
The Institute of Genomics and Global Health, Redeemer’s University, Ede, Nigeria
3 shared publications - Grace Olusola Gbotosho
Affiliations Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria, Malaria Research Laboratories, Institute for Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria, Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria
3 shared publications - Akintunde Sowunmi
Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
2 shared publications Akin Sowunmi
Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan
1 shared publication- Ayoade Mj Oduola
Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland
1 shared publication - Ayoade Oduola
Stewardship for Research, Tropical Disease Research (TDR), World Health Organization, Geneva, Switzerland
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 59
A high performance liquid chromatographic assay of Mefloquine in saliva after a single oral dose in healthy adult Africans
- 1 January 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 59
Open AccessA high performance liquid chromatographic assay of Mefloquine in saliva after a single oral dose in healthy adult Africans
- Open Access
- 15 February 2010
- Published by Springer Nature in Malaria Journal
- Vol. 9 (1) , 53
Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children
Drug resistance in Plasmodium falciparum is common in many endemic and other settings but there is no clear recommendation on when to change therapy when there is delay in parasite clearance after initiation of therapy in African children.
- 15 February 2010
- Published by Springer Nature in Malaria Journal
- Vol. 9 (1) , 53
Open AccessFactors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children
Drug resistance in Plasmodium falciparum is common in many endemic and other settings but there is no clear recommendation on when to change therapy when there is delay in parasite clearance after initiation of therapy in African children.
- Open Access
- 24 October 2009
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1) , 238
A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies
Artesunate plus sulphadoxine-pyrimethamine is one of the four artemisinin-based combination therapies currently recommended by WHO as first-line treatment for falciparum malaria. Sulphadoxine-pyrimethamine is also used for intermittent preventive treatment for malaria in pregnancy. Drug use patterns and drug pharmacokinetics are important factors impacting the spread of drug resistant parasites hence it is imperative to monitor the effect of pharmacokinetic variability on therapeutic efficacy. Unfortunately, information on the pharmacokinetics of sulphadoxine in children and pregnant women with malaria is very limited. Methods for the assay of sulphadoxine-pyrimethamine have been previously reported, but they are not cost-effective and practicable in analytical laboratories in low resource areas where malaria is endemic. Efforts in this study were thus devoted to development and evaluation of a simple, cost-effective and sensitive method for quantification of sulphadoxine in small capillary samples of whole blood dried on filter paper.
- 24 October 2009
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1) , 238
Open AccessA simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies
Artesunate plus sulphadoxine-pyrimethamine is one of the four artemisinin-based combination therapies currently recommended by WHO as first-line treatment for falciparum malaria. Sulphadoxine-pyrimethamine is also used for intermittent preventive treatment for malaria in pregnancy. Drug use patterns and drug pharmacokinetics are important factors impacting the spread of drug resistant parasites hence it is imperative to monitor the effect of pharmacokinetic variability on therapeutic efficacy. Unfortunately, information on the pharmacokinetics of sulphadoxine in children and pregnant women with malaria is very limited. Methods for the assay of sulphadoxine-pyrimethamine have been previously reported, but they are not cost-effective and practicable in analytical laboratories in low resource areas where malaria is endemic. Efforts in this study were thus devoted to development and evaluation of a simple, cost-effective and sensitive method for quantification of sulphadoxine in small capillary samples of whole blood dried on filter paper.